Taiho Pharmaceutical Obtains Approval to Manufacture and Market NK1 Receptor Antagonist Arokaris® I.V. Infusion 235mg in Japan
Taiho Pharmaceutical Obtains Approval to Manufacture and Market NK1 Receptor Antagonist Arokaris®I.V. Infusion 235mg in…
Taiho Pharmaceutical Obtains Approval to Manufacture and Market NK1 Receptor Antagonist Arokaris®I.V. Infusion 235mg in…
Expects to add two U.S. Food and Drug Administration (“FDA”)-approved, new chemical entities (“NCEs”) with…
TOKYO, Mar 28, 2022 – (JCN Newswire) – Mitsubishi Heavy Industries EMEA, Ltd. (MHI-EMEA), MHI’s…
ChargePoint will work with Gatik to establish electric vehicle charging infrastructure and integrated services for…
SEATTLE–(BUSINESS WIRE)–$AVLR—Avalara (NYSE: AVLR), a leading provider of tax compliance automation software for businesses of…
MOORESTOWN, N.J.–(BUSINESS WIRE)–OPEX® Corporation, a global leader in warehouse automation technology, has added an innovative,…
Developer of touchless wireless charging using award-winning WattUp wireless power transfer technology for new applications…
NEW YORK–(BUSINESS WIRE)–#AssetClass–H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $48 billion of…
ChargePoint will work with Gatik to establish electric vehicle charging infrastructure and integrated services for…
London, [28th March 2022] – Logicalis, an international IT solutions and managed service provider, announced…
Closing Bell Ringing Ceremony Will Take Place on Monday, March 28 at 3:45 pm ET at…
Xenpozyme® (olipudase alfa) approved in Japan, first and only approved therapy indicated to treat acid…
Approval of additional indication based on Phase 2b/3 SELECTION study in patients with moderate-to-severe ulcerative…
ACACIA PHARMA GROUP PLC PROPOSED TRANSACTION WITH EAGLE PHARMACEUTICALS, INC. THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION…
For immediate release iSTAR Medical Continues Market Expansion with First MINIject®Surgeries in the UK UK…
Leuven, BELGIUM, Boston, MA, US – MARCH 28, 2022 – 8.00 AM CET – Oxurion…
NFL Biosciences: 2021 full-year business and earnings update Phase II/III clinical trial rolled out for…
TOKYO, Mar 28, 2022 – (JCN Newswire) – Showa Denko K.K. (SDK) (TOKYO: 4004) has…
WASHINGTON & BRUSSELS–(BUSINESS WIRE)–EIG, a leading institutional investor to the global energy and infrastructure sectors,…
£170 million DSR Guarantee for Yorkshire Water Services Limited LONDON–(BUSINESS WIRE)–Assured Guaranty UK Limited (AGUK)*…